[1. Frangogiannis NG. Pathophysiology of Myocardial Infarction. Compr Physiol. 2015;5:1841-75. DOI: 10.1002/cphy.c15000610.1002/cphy.c15000626426469]Open DOISearch in Google Scholar
[2. Prabhu SD, Frangogiannis NG. The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. Circ Res. 2016;119:91-112. DOI: 10.1161/CIRCRESAHA.116.30357710.1161/CIRCRESAHA.116.303577492252827340270]Open DOISearch in Google Scholar
[3. Kain V, Prabhu SD, Halade GV. Inflammation revisited: inflammation versus resolution of inflammation following myocardial infarction. Basic Res Cardiol. 2014;109:444. DOI: 10.1007/s00395-014-0444-710.1007/s00395-014-0444-725248433]Open DOISearch in Google Scholar
[4. Swirski FK. Inflammation and repair in the ischaemic myocardium. Hamostaseologie. 2015;35:34-6. DOI: 10.5482/HAMO-14-09-004510.5482/HAMO-14-09-004525375277]Open DOISearch in Google Scholar
[5. Yan X, Anzai A, Katsumata Y, Matsuhashi T, Ito K, Endo J, et al. Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction. J Mol Cell Cardiol. 2013;62:24-35. DOI: 10.1016/j.yjmcc.2013.04.02310.1016/j.yjmcc.2013.04.02323644221]Open DOISearch in Google Scholar
[6. Ma Y, Yabluchanskiy A, Iyer RP, Cannon PL, Flynn ER, Jung M, et al. Temporal neutrophil polarization following myocardial infarction. Cardiovasc Res. 2016;110:51-61. DOI: 10.1093/cvr/cvw02410.1093/cvr/cvw024479804626825554]Open DOISearch in Google Scholar
[7. Chan JK, Roth J, Oppenheim JJ, Tracey KJ, Vogl T, Feldmann M, et al. Alarmins: awaiting a clinical response. J Clin Invest. 2012;122:2711-9. DOI: 10.1172/JCI6242310.1172/JCI62423340874022850880]Open DOISearch in Google Scholar
[8. Arslan F, de Kleijn DP and Pasterkamp G. Innate immune signaling in cardiac ischemia. Nat Rev Cardiol. 2011;8:292-300. DOI: 10.1038/nrcardio.2011.3810.1038/nrcardio.2011.3821448140]Search in Google Scholar
[9. Mann DL. The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls. Circ Res. 2011;108:1133-45. DOI: 10.1161/CIRCRESAHA. 110.22693610.1161/CIRCRESAHA.110.226936308498821527743]Open DOISearch in Google Scholar
[10. Mathur S, Walley KR, Wang Y, Indrambarya T, Boyd JH. Extracellular heat shock protein 70 induces cardiomyocyte inflammation and contractile dysfunction via TLR2. Circ J. 2011;75:2445-52.DOI: 10.1253/circj.CJ-11-019410.1253/circj.CJ-11-019421817814]Search in Google Scholar
[11. Riva M, Kallberg E, Bjork P, Hancz D, Vogl T, Roth J, et al. Induction of nuclear factor-kappaB responses by the S100A9 protein is Toll-like receptor-4-dependent. Immunology. 2012;137:172-82. DOI: 10.1111/j.1365-2567.2012.03619.x10.1111/j.1365-2567.2012.03619.x]Open DOISearch in Google Scholar
[12. Ryckman C, Vandal K, Rouleau P, Talbot M, Tessier PA. Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J Immunol. 2003;170:3233-42. DOI: 10.4049/jimmunol.170.6.323310.4049/jimmunol.170.6.3233]Open DOISearch in Google Scholar
[13. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002;418:191-5. DOI: 10.1038/nature0085810.1038/00858]Open DOISearch in Google Scholar
[14. Kleinbongard P, Heusch G, Schulz R. TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure. Pharmacol Ther. 2010;127:295-314. DOI: 10.1016/j.pharmthera.2010.05.00210.1016/j.pharmthera.2010.05.002]Open DOISearch in Google Scholar
[15. Bujak M, Dobaczewski M, Chatila K, Mendoza LH, Li N, Reddy A, Frangogiannis NG. Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. Am J Pathol. 2008;173:57-67. DOI: 10.2353/ajpath.2008.07097410.2353/ajpath.2008.070974]Open DOISearch in Google Scholar
[16. Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc res. 2004;61:481-97. DOI: 10.1016/j.cardiores.2003.10.01110.1016/j.cardiores.2003.10.011]Open DOISearch in Google Scholar
[17. Carbone F, Nencioni A, Mach F, Vuilleumier N, Montecucco F. Pathophysiological role of neutrophils in acute myocardial infarction. Thromb Haemost. 2013;110:501-14. DOI: 10.1160/TH13-03-021110.1160/TH13-03-0211]Open DOISearch in Google Scholar
[18. Horckmans M, Ring L, Duchene J, Santovito D, Schloss MJ, Drechsler M, et al. Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype. Eur Heart J.2017;38:187-197.]Search in Google Scholar
[19. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 2003;19:71-82. DOI: 10.1016/ S1074-7613(03)00174-210.1016/S1074-7613(03)00174-2]Open DOISearch in Google Scholar
[20. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol. 2005;5:953-64. DOI: 10.1038/nri1733 10.1038/nri173316322748]Open DOISearch in Google Scholar
[21. Swirski FK, Nahrendorf M. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science. 2013;339:161-6. DOI: 10.1126/science.123071910.1126/.1230719]Open DOISearch in Google Scholar
[22. Wantha S, Alard JE, Megens RT, van der Does AM, Doring Y, Drechsler M, et al. Neutrophil-derived cathelicidin promotes adhesion of classical monocytes. Circ Res. 2013;112:792-801. DOI: 10.1161/CIRCRESAHA.112.30066610.1161/CIRCRESAHA.112.300666370217323283724]Open DOISearch in Google Scholar
[23. Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo JL, et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med. 2007;204:3037-47.DOI: 10.1084/jem.2007088510.1084/jem.20070885211851718025128]Open DOISearch in Google Scholar
[24. Leuschner F, Dutta P, Gorbatov R, Novobrantseva TI, Donahoe JS, Courties G, et al. Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat Biotechnol. 2011;29:1005-10. DOI: 10.1038/nbt.198910.1038/nbt.1989321261421983520]Search in Google Scholar
[25. Sager HB, Heidt T, Hulsmans M, Dutta P, Courties G, Sebas M, et al. Targeting Interleukin-1beta Reduces Leukocyte Production After Acute Myocardial Infarction. Circulation. 2015;132:1880-90.10.1161/CIRCULATIONAHA.115.016160465179526358260]Search in Google Scholar
[26. Swirski FK, Nahrendorf M, Etzrodt M, Wildgruber M, Cortez-Retamozo V, Panizzi P, et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science. 2009;325:612-6. DOI: 10.1126/science.117520210.1126/.1175202]Open DOISearch in Google Scholar
[27. Leuschner F, Rauch PJ, Ueno T, Gorbatov R, Marinelli B, Lee WW, et al. Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. J Exp Med. 2012;209:123-37. DOI: 10.1084/jem.2011100910.1084/jem.20111009326087522213805]Open DOISearch in Google Scholar
[28. Dutta P, Courties G, Wei Y, Leuschner F, Gorbatov R, Robbins CS, et al. Myocardial infarction accelerates atherosclerosis. Nature. 2012;487:325-9. DOI: 10.1038/nature1126010.1038/11260]Open DOISearch in Google Scholar
[29. van der Laan AM, Ter Horst EN, Delewi R, Begieneman MP, Krijnen PA, Hirsch A, et al. Monocyte subset accumulation in the human heart following acute myocardial infarction and the role of the spleen as monocyte reservoir. Eur Heart J. 2014;35:376-85. DOI: 10.1093/eurheartj/eht33110.1093/eurheartj/eht331391677623966310]Open DOISearch in Google Scholar
[30. Tsujioka H, Imanishi T, Ikejima H, Kuroi A, Takarada S, Tanimoto T, et al. Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction. J Am Coll Cardiol. 2009;54:130-8. DOI: 10.1016/j.jacc.2009.04.02110.1016/j.jacc.2009.04.02119573729]Search in Google Scholar
[31. Hashimoto D, Chow A, Noizat C, Teo P, Beasley MB, Leboeuf M, et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity. 2013;38:792-804. DOI: 10.1016/j.immuni.2013.04.00410.1016/j.immuni.2013.04.004385340623601688]Open DOISearch in Google Scholar
[32. Yona S, Kim KW, Wolf Y, Mildner A, Varol D, Breker M, et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity. 2013;38:79-91. DOI: 10.1016/j.immuni.2012.12.00110.1016/j.immuni.2012.12.001390854323273845]Open DOISearch in Google Scholar
[33. Epelman S, Lavine KJ, Beaudin AE, Sojka DK, Carrero JA, Calderon B, et al. Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity. 2014;40:91-104. DOI: 10.1016/j.immuni.2013.11.01910.1016/j.immuni.2013.11.019392330124439267]Open DOISearch in Google Scholar
[34. Ginhoux F, Jung S. Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat Rev Immunol. 2014;14:392-404. DOI: 10.1038/nri367110.1038/nri367124854589]Open DOISearch in Google Scholar
[35. Hanna RN, Carlin LM, Hubbeling HG, Nackiewicz D, Green AM, Punt JA, et al. The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C- monocytes. Nat Immunol. 2011;12:778-85. DOI: 10.1038/ni.206310.1038/ni.2063332439521725321]Open DOISearch in Google Scholar
[36. Hilgendorf I, Gerhardt L, Tan TC, Winter C, Holderried TA, Chousterman BG, et al. Ly-6Chigh Monocytes Depend on Nr4a1 to Balance both Inflammatory and Reparative Phases in the Infarcted Myocardium. Circ Res. 2014. DOI: 10.1161/CIRCRESAHA.114.30320410.1161/CIRCRESAHA.114.303204401734924625784]Open DOISearch in Google Scholar
[37. van Amerongen MJ, Harmsen MC, van Rooijen N, Petersen AH, van Luyn MJ. Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice. Am J Pathol. 2007;170:818-29. DOI: 10.2353/ajpath.2007.06054710.2353/ajpath.2007.060547186489317322368]Open DOISearch in Google Scholar
[38. Leblond AL, Klinkert K, Martin K, Turner EC, Kumar AH, Browne T, Caplice NM. Systemic and Cardiac Depletion of M2 Macrophage through CSF-1R Signaling Inhibition Alters Cardiac Function Post Myocardial Infarction. PLoS One. 2015;10:e0137515. DOI: 10.1371/journal.pone.013751510.1371/journal.pone.0137515458322626407006]Search in Google Scholar
[39. Howangyin KY, Zlatanova I, Pinto C, Ngkelo A, Cochain C, Rouanet M, et al. Myeloid-Epithelial-Reproductive Receptor Tyrosine Kinase and Milk Fat Globule Epidermal Growth Factor 8 Coordinately Improve Remodeling After Myocardial Infarction via Local Delivery of Vascular Endothelial Growth Factor. Circulation. 2016;133:826-39. DOI: 10.1161/CIRCULATIONAHA.115.02085710.1161/CIRCULATIONAHA.115.020857476710926819373]Search in Google Scholar
[40. Wan E, Yeap XY, Dehn S, Terry R, Novak M, Zhang S, et al. Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction. Circ Res. 2013;113:1004-12. DOI: 10.1161/CIRCRESAHA.113.30119810.1161/CIRCRESAHA.113.301198384046423836795]Open DOISearch in Google Scholar
[41. Jugdutt BI. Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? Circulation. 2003;108:1395-403. DOI: 10.1161/01.CIR.0000085658.98621.4910.1161/01.CIR.0000085658.98621.4912975244]Open DOISearch in Google Scholar
[42. Mollmann H, Nef HM, Kostin S, von Kalle C, Pilz I, Weber M, et al. Bone marrow-derived cells contribute to infarct remodelling. Cardiovasc res. 2006;71:661-71. DOI: 10.1016/j.cardiores.2006.06.013 10.1016/j.cardiores.2006.06.01316854401]Open DOISearch in Google Scholar
[43. Ruiz-Villalba A, Simon AM, Pogontke C, Castillo MI, Abizanda G, Pelacho B, et al. Interacting resident epicardium- derived fibroblasts and recruited bone marrow cells form myocardial infarction scar. J Am Coll Cardiol. 2015;65:2057-66. DOI: 10.1016/j.jacc.2015.03.52010.1016/j.jacc.2015.03.52025975467]Open DOISearch in Google Scholar
[44. Yano T, Miura T, Ikeda Y, Matsuda E, Saito K, Miki T, et al. Intracardiac fibroblasts, but not bone marrow derived cells, are the origin of myofibroblasts in myocardial infarct repair. Cardiovasc Pathol. 2005;14:241-6. DOI: 10.1016/j.carpath.2005.05.00410.1016/j.carpath.2005.05.00416168896]Open DOISearch in Google Scholar
[45. Cochain C, Channon KM, Silvestre JS. Angiogenesis in the infarcted myocardium. Antioxidants & redox signaling. 2013;18:1100-13. DOI: 10.1089/ars.2012.484910.1089/ars.2012.4849356778322870932]Open DOISearch in Google Scholar
[46. Mann DL. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res. 2002;91:988-98. DOI: 10.1161/01. RES.0000043825.01705.1B10.1161/01.RES.0000043825.01705.1]Open DOISearch in Google Scholar
[47. Bozkurt B, Mann DL, Deswal A. Biomarkers of inflammation in heart failure. Heart Fail Rev. 2010;15:331-41. DOI: 10.1007/s10741-009-9140-3 10.1007/s10741-009-9140-319363700]Open DOISearch in Google Scholar
[48. Ismahil MA, Hamid T, Bansal SS, Patel B, Kingery JR, Prabhu SD. Remodeling of the mononuclear phagocyte network underlies chronic inflammation and disease progression in heart failure: critical importance of the cardiosplenic axis. Circ Res. 2014;114:266-82.DOI: 10.1161/CIRCRESAHA.113.30172010.1161/CIRCRESAHA.113.301720592852024186967]Open DOISearch in Google Scholar
[49. Odegaard JI, Chawla A. Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science. 2013;339:172-7. DOI: 10.1126/science. 123072110.1126/.1230721]Open DOISearch in Google Scholar
[50. Nagareddy PR, Kraakman M, Masters SL, Stirzaker RA, Gorman DJ, Grant RW, et al. Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity. Cell metab. 2014;19:821-35. DOI: 10.1016/j.cmet.2014.03.02910.1016/j.cmet.2014.03.029404893924807222]Open DOISearch in Google Scholar
[51. Jernberg T, Hasvold P, Henriksson M, Hjelm H, Thuresson M, Janzon M. Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective. Eur Heart J. 2015;36:1163-70. DOI: 10.1093/eurheartj/ehu50510.1093/eurheartj/ehu50525586123]Open DOISearch in Google Scholar
[52. Nahrendorf M, Swirski FK. Innate immune cells in ischaemic heart disease: does myocardial infarction beget myocardial infarction? Eur Heart J. 2016;37:868-72. DOI: 10.1093/eurheartj/ehv45310.1093/eurheartj/ehv453]Open DOISearch in Google Scholar
[53. Seropian IM, Toldo S, Van Tassell BW, Abbate A. Anti- inflammatory strategies for ventricular remodeling following ST-segment elevation acute myocardial infarction. J Am Coll Cardiol. 2014;63:1593-603. DOI: 10.1016/j.jacc.2014.01.01410.1016/j.jacc.2014.01.014]Open DOISearch in Google Scholar
[54. Giugliano GR, Giugliano RP, Gibson CM, Kuntz RE. Meta-analysis of corticosteroid treatment in acute myocardial infarction. Am J Cardiol. 2003;91:1055-9. DOI: 10.1016/S0002-9149(03)00148-610.1016/S0002-9149(03)00148-6]Open DOISearch in Google Scholar
[55. Gibson CM, Pride YB, Aylward PE, Col JJ, Goodman SG, Gulba D, et al. Association of non-steroidal anti- inflammatory drugs with outcomes in patients with ST-segment elevation myocardial infarction treated with fibrinolytic therapy: an ExTRACT-TIMI 25 analysis. J Thromb Thrombolysis. 2009;27:11-7. DOI: 10.1007/s11239-008-0264-410.1007/s11239-008-0264-418695943]Open DOISearch in Google Scholar
[56. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33:2569-619.]Search in Google Scholar
[57. Morton AC, Rothman AM, Greenwood JP, Gunn J, Chase A, Clarke B, et al. The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study. Eur Heart J. 2015;36:377-84. DOI: 10.1093/eurheartj/ehu27210.1093/eurheartj/ehu272432032125079365]Open DOISearch in Google Scholar
[58. Ridker PM, Thuren T, Zalewski A, Libby P. Interleukin- 1beta inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS). Am Heart J. 2011;162:597-605. DOI: 10.1016/j.ahj.2011.06.01210.1016/j.ahj.2011.06.01221982649]Open DOISearch in Google Scholar
[59. Swirski FK, Robbins CS. Neutrophils usher monocytes into sites of inflammation. Circ Res. 2013;112:744-5. DOI: 10.1161/CIRCRESAHA.113.30086710.1161/CIRCRESAHA.113.30086723449542]Open DOISearch in Google Scholar